vimarsana.com

Latest Breaking News On - ஹனா பார்ம் - Page 1 : vimarsana.com

EQS-News: PAION STARTET VERMARKTUNG VON BYFAVO(R) (REMIMAZOLAM) IN DER | Newsticker

EQS-News: PAION STARTET VERMARKTUNG VON BYFAVO(R) (REMIMAZOLAM) IN DER | Newsticker
fuw.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fuw.ch Daily Mail and Mail on Sunday newspapers.

PAION RECEIVES UK MHRA APPROVAL OF BYFAVO (REMIMAZOLAM) FOR PROCEDURAL SEDATION

PAION RECEIVES UK MHRA APPROVAL OF BYFAVO (REMIMAZOLAM) FOR PROCEDURAL SEDATION
dgap.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dgap.de Daily Mail and Mail on Sunday newspapers.

​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021

​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021 DGAP-News: PAION AG / Key word(s): Quarterly / Interim Statement 12.05.2021 / 07:30 PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021 - Remimazolam launches in the U.S. and South Korea in the first quarter of 2021 - EU market approval received for remimazolam in procedural sedation in March 2021 - Good progress in commercialization of remimazolam in the U.S., Japan, China and South Korea through our partners - Expansion of European product portfolio with GIAPREZA (R) and XERAVA - Successful rights issue of EUR 7.8 million completed in April 2021 - Revenues of EUR 3.2 million

PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM

PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM DGAP-News: PAION AG / Key word(s): Market launch 07.04.2021 / 09:00 PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO TM (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM Aachen (Germany), 07 April 2021 - The Specialty Pharma Company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that Hana Pharm, remimazolam licensee for South Korea, informed PAION about the launch of Byfavo TM (remimazolam) for the use in general anesthesia in South Korea. Remimazolam was approved in South Korea for general anesthesia in January 2021 and will be marketed under the brand name Byfavo

Investegate |PAION AG Announcements | PAION AG: PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM

Investegate |PAION AG Announcements | PAION AG: PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.